Pharma Geftinib 250mg

Get a Price/Quote

MOQ : 1 Pallet

Pharma Geftinib 250mg Specification

Life Span
24 months from date of manufacture

Indication
Treatment of locally advanced or metastatic non-small cell lung cancer

Dosage Form
Tablet

Brand Name
Gefitinib 250mg

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 tablets per box

Salt Composition
Gefitinib 250 mg

Packaging Type
Box

Drug Type
Allopathic

Ingredients
Gefitinib

Physical Form
Tablets

Function
Anti-cancer (EGFR inhibitor)

Recommended For
Non-Small Cell Lung Cancer patients

Dosage
250 mg once daily or as directed by physician

Dosage Guidelines
Take orally, with or without food, as prescribed by a healthcare provider

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 25C; protect from light and moisture

Prescription Status
Prescription only

Administration Route
Oral

Side Effects
Skin reactions, diarrhea, nausea, vomiting, loss of appetite, increased liver enzymes

Warning and Precautions
Not recommended during pregnancy and lactation. Use caution in patients with impaired hepatic or renal function.

Inactive Ingredients
Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulphate, magnesium stearate

Shelf Life
2 years from date of manufacture

Contraindications
Known hypersensitivity to Gefitinib or any other component of the tablet

Standard Packaging
Blister pack inside a box

Market Approval
WHO-GMP approved facility manufacture

About Pharma Geftinib 250mg

Discover the trending Geftinib 250mg tablets, a laureate in targeted cancer therapy, renowned for its efficacy in managing non-small cell lung cancer (NSCLC). Manufactured in a rarefied WHO-GMP approved facility in India, this prescription-only oral EGFR inhibitor offers patients a reliable option in cancer care. Each blister pack offers 30 tablets and is optimally composed with select inactive ingredients to support tolerability. Buy online from leading distributors and suppliers, and ensure professional guidance for use, especially regarding side effects and contraindications. Store below 25C, away from light and moisture. Only for adult use, strictly as prescribed.

Geftinib 250mg: Medical Application and Usage

Geftinib 250mg is primarily applied for the treatment of locally advanced or metastatic non-small cell lung cancer in adults. Its type of usage is strictly medicinal under a healthcare provider's supervision. Appropriate application places include oncology departments in hospitals, cancer treatment clinics, and specialized healthcare centers. The oral tablet form enables patients to administer the dose conveniently at home, as per their physician's prescribed course.

Geftinib 250mg Packaging and Sample Policy

Each shipment of Geftinib 250mg arrives in standard blister packs, enclosed inside a secure box, containing 30 tablets per package. For distributors and traders evaluating a proposal amount or list price, sample availability can be discussed in accordance with company sample policy. This formulation is shipped from India, ensuring quality is maintained during transit. Packaging ensures patient safety and medicine efficacy throughout its 24-month lifespan from the date of manufacture.

FAQ's of Geftinib 250mg:

Q: How should Geftinib 250mg tablets be taken for best results?

A: Geftinib 250mg should be taken orally, once daily, with or without food, as directed by your healthcare provider. It is important to follow the prescribed dosage and not exceed the recommended amount.

Q: What are the main benefits of using Geftinib 250mg for cancer treatment?

A: The main benefit of Geftinib 250mg is its targeted action on EGFR, offering improved management of locally advanced or metastatic non-small cell lung cancer and potentially improving progression-free survival in eligible adults.

Q: When should patients avoid using Geftinib 250mg?

A: Patients with known hypersensitivity to Gefitinib or any tablet components should avoid this medication. It is also not recommended during pregnancy, lactation, or in those with significant liver or kidney impairment unless closely monitored.

Q: Where is Geftinib 250mg manufactured and by which standards?

A: Geftinib 250mg is manufactured in India in a renowned facility that is WHO-GMP approved, ensuring international standards for drug safety and efficacy are met.

Q: What should be considered during the storage and handling of Geftinib 250mg?

A: Store Geftinib 250mg below 25C, protected from light and moisture. Always keep it in its original blister packaging within the box until use to maintain its therapeutic effectiveness.

Tell us about your requirement